Clinical Trials Browser

NIH × Uveal Melanoma × aldesleukin × Clear all

NCT01814046 2018-10-11

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma

Phase 2 Terminated

24 enrolled 13 charts

Uveal Melanoma, Neoplasm Metastasis

NCT00058279 2013-06-20

Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

Phase 1/2 Completed

Uveal Melanoma, Melanoma